Nilotinib, for Patients With CML-CP or CML-AP
Clinical trial NCT04518644 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT04518644
- Sponsor
- Novartis Pharmaceuticals
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.